65,437 trials
Colon Cancer With Metastases to the Liver
Primary: Tumor Response — 31; 16 participants
Chronic Low-back Pain
Primary: Mean Change in Subcortical Brain Structure Volume — 0.054; 0.74; 0.27; 0.48 cubic centimeters — p=>0.05
Influenza, Human
Primary: Number of Subjects With Solicited Local Adverse Events (AEs) After First Dose Administration — 1; 3; 2; 2 Participants
Dry Mouth
Primary: Response to "Relieving the Discomfort of Dry Mouth" From the Modified PPAQ I 4- and 6-hours Post-use on Day 1 of Treatment — 2.51; 3.26; 3.43 score on a scale
Obesity · Primary Care · Health Communication
Primary: Treatment Acceptability Questionnaire — 35.8 units on a scale
Asthma
Primary: Change in FEV1 (% Predicted) — 13.8; 9.1 %predicted — p=0.04
Tobacco Use Disorder · Smoking Cessation
Primary: Emotional Reactivity By Pharmacotherapy — 66.6; 64.7; 65.6; 70.9 microvolts
Dementia, Alzheimer Type
Primary: ADAS-Cog v14 — -1.5; -0.7 units on a scale
Urinary Catheterization
Primary: Subjects' Perception at Insertion of Test Catheter Activated for 5 Seconds, Compared to Reference. — 3; 10; 5; 6 participants — p=0.0650
Non-Small Cell Lung Cancer
Primary: Progression-Free Survival (PFS), Groups A-D Only — 15.0; 6.7; 6.0; 5.9 Months — p=0.5050
Dementia
Primary: Change in Neuropsychiatric Inventory (NPI) — -32.79 units on a scale
Bradycardia
Primary: Chronic CareLink Transmission Success — 94.6; 60.0; 56.3 Percentage of completed transmissions — p=<0.001
Healthy Adults · Genetic Predisposition to Disease
Primary: Active-duty Airmen's Perceptions About Military Use of Genomic Information to Make Career Decisions — 2.62; 2.66 score on a scale
Macular Degeneration
Primary: Time Until a Participant First Requires the Implant Refill According to Protocol-Defined Refill Criteria — 8.7; 13.0; 15.8 Months
Alcohol; Harmful Use · Sex, Unsafe
Primary: Number of Heavy Drinking Episodes NIAAA Criteria (5 or More Drinks on a Single Occasion) — 3.09; 5.33 heavy drinking episodes — p=.048